Cargando…

Growth environment and organ specific variation in in-vitro cytoprotective activities of Picea mariana in PC12 cells exposed to glucose toxicity: a plant used for treatment of diabetes symptoms by the Cree of Eeyou Istchee (Quebec, Canada)

BACKGROUND: The Cree of Eeyou Istchee (James Bay area of northern Quebec) suffer from a high rate of diabetes and its complications partly due to the introduction of the western lifestyle within their culture. As part of a search for alternative medicine based on traditional practice, this project e...

Descripción completa

Detalles Bibliográficos
Autores principales: Downing, Ashleigh D., Eid, Hoda M., Tang, Andrew, Ahmed, Fida, Harris, Cory S., Haddad, Pierre S., Johns, Timothy, Arnason, John T., Bennett, Steffany A. L., Cuerrier, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582571/
https://www.ncbi.nlm.nih.gov/pubmed/31215420
http://dx.doi.org/10.1186/s12906-019-2550-4
_version_ 1783428351460900864
author Downing, Ashleigh D.
Eid, Hoda M.
Tang, Andrew
Ahmed, Fida
Harris, Cory S.
Haddad, Pierre S.
Johns, Timothy
Arnason, John T.
Bennett, Steffany A. L.
Cuerrier, Alain
author_facet Downing, Ashleigh D.
Eid, Hoda M.
Tang, Andrew
Ahmed, Fida
Harris, Cory S.
Haddad, Pierre S.
Johns, Timothy
Arnason, John T.
Bennett, Steffany A. L.
Cuerrier, Alain
author_sort Downing, Ashleigh D.
collection PubMed
description BACKGROUND: The Cree of Eeyou Istchee (James Bay area of northern Quebec) suffer from a high rate of diabetes and its complications partly due to the introduction of the western lifestyle within their culture. As part of a search for alternative medicine based on traditional practice, this project evaluates the biological activity of Picea mariana (Mill.) Britton, Sterns & Poggenb. needle, bark, and cone, in preventing glucose toxicity to PC12-AC cells in vitro (a diabetic neurophathy model) and whether habitat and growth environment influence this activity. METHODS: Three different organs (needle, bark, and cone) of P. mariana were collected at different geographical locations and ecological conditions and their 80% ethanolic extracts were prepared. Extracts were then tested for their ability to protect PC12-AC cells from hyperglycaemic challenge at physiologically relevant concentrations of 0.25, 0.5, 1.0 and 2.0 μg/mL. Folin-Ciocalteu method was used to determine the total phenolic content of P. mariana extracts. RESULTS: All extracts were well-tolerated in vitro exhibiting LD(50) of 25 μg/mL or higher. Extracts from all tested organs showed a cytoprotective concentration-dependent response. Furthermore, the cytoprotective activity was habitat- and growth environment-dependent with plants grown in bog or forest habitats in coastal or inland environments exhibiting different cytoprotective efficacies. These differences in activity correlated with total phenolic content but not with antioxidant activity. In addition, this paper provides the first complete Ultra-Performance Liquid Chromatography-quadrupole time-of-flight (UPLC-QTOF) mass spectrometry analysis of Picea mariana’s bark, needles and cones. CONCLUSIONS: Together, these results provide further understanding of the cytoprotective activity of Canadian boreal forest plants identified by the Cree healers of Eeyou Istchee in a cell model of diabetic neuropathy. Their activity is relevant to diabetic peripheral neuropathic complications and shows that their properties can be optimized by harvesting in optimal growth environments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12906-019-2550-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6582571
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65825712019-06-26 Growth environment and organ specific variation in in-vitro cytoprotective activities of Picea mariana in PC12 cells exposed to glucose toxicity: a plant used for treatment of diabetes symptoms by the Cree of Eeyou Istchee (Quebec, Canada) Downing, Ashleigh D. Eid, Hoda M. Tang, Andrew Ahmed, Fida Harris, Cory S. Haddad, Pierre S. Johns, Timothy Arnason, John T. Bennett, Steffany A. L. Cuerrier, Alain BMC Complement Altern Med Research Article BACKGROUND: The Cree of Eeyou Istchee (James Bay area of northern Quebec) suffer from a high rate of diabetes and its complications partly due to the introduction of the western lifestyle within their culture. As part of a search for alternative medicine based on traditional practice, this project evaluates the biological activity of Picea mariana (Mill.) Britton, Sterns & Poggenb. needle, bark, and cone, in preventing glucose toxicity to PC12-AC cells in vitro (a diabetic neurophathy model) and whether habitat and growth environment influence this activity. METHODS: Three different organs (needle, bark, and cone) of P. mariana were collected at different geographical locations and ecological conditions and their 80% ethanolic extracts were prepared. Extracts were then tested for their ability to protect PC12-AC cells from hyperglycaemic challenge at physiologically relevant concentrations of 0.25, 0.5, 1.0 and 2.0 μg/mL. Folin-Ciocalteu method was used to determine the total phenolic content of P. mariana extracts. RESULTS: All extracts were well-tolerated in vitro exhibiting LD(50) of 25 μg/mL or higher. Extracts from all tested organs showed a cytoprotective concentration-dependent response. Furthermore, the cytoprotective activity was habitat- and growth environment-dependent with plants grown in bog or forest habitats in coastal or inland environments exhibiting different cytoprotective efficacies. These differences in activity correlated with total phenolic content but not with antioxidant activity. In addition, this paper provides the first complete Ultra-Performance Liquid Chromatography-quadrupole time-of-flight (UPLC-QTOF) mass spectrometry analysis of Picea mariana’s bark, needles and cones. CONCLUSIONS: Together, these results provide further understanding of the cytoprotective activity of Canadian boreal forest plants identified by the Cree healers of Eeyou Istchee in a cell model of diabetic neuropathy. Their activity is relevant to diabetic peripheral neuropathic complications and shows that their properties can be optimized by harvesting in optimal growth environments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12906-019-2550-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-18 /pmc/articles/PMC6582571/ /pubmed/31215420 http://dx.doi.org/10.1186/s12906-019-2550-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Downing, Ashleigh D.
Eid, Hoda M.
Tang, Andrew
Ahmed, Fida
Harris, Cory S.
Haddad, Pierre S.
Johns, Timothy
Arnason, John T.
Bennett, Steffany A. L.
Cuerrier, Alain
Growth environment and organ specific variation in in-vitro cytoprotective activities of Picea mariana in PC12 cells exposed to glucose toxicity: a plant used for treatment of diabetes symptoms by the Cree of Eeyou Istchee (Quebec, Canada)
title Growth environment and organ specific variation in in-vitro cytoprotective activities of Picea mariana in PC12 cells exposed to glucose toxicity: a plant used for treatment of diabetes symptoms by the Cree of Eeyou Istchee (Quebec, Canada)
title_full Growth environment and organ specific variation in in-vitro cytoprotective activities of Picea mariana in PC12 cells exposed to glucose toxicity: a plant used for treatment of diabetes symptoms by the Cree of Eeyou Istchee (Quebec, Canada)
title_fullStr Growth environment and organ specific variation in in-vitro cytoprotective activities of Picea mariana in PC12 cells exposed to glucose toxicity: a plant used for treatment of diabetes symptoms by the Cree of Eeyou Istchee (Quebec, Canada)
title_full_unstemmed Growth environment and organ specific variation in in-vitro cytoprotective activities of Picea mariana in PC12 cells exposed to glucose toxicity: a plant used for treatment of diabetes symptoms by the Cree of Eeyou Istchee (Quebec, Canada)
title_short Growth environment and organ specific variation in in-vitro cytoprotective activities of Picea mariana in PC12 cells exposed to glucose toxicity: a plant used for treatment of diabetes symptoms by the Cree of Eeyou Istchee (Quebec, Canada)
title_sort growth environment and organ specific variation in in-vitro cytoprotective activities of picea mariana in pc12 cells exposed to glucose toxicity: a plant used for treatment of diabetes symptoms by the cree of eeyou istchee (quebec, canada)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582571/
https://www.ncbi.nlm.nih.gov/pubmed/31215420
http://dx.doi.org/10.1186/s12906-019-2550-4
work_keys_str_mv AT downingashleighd growthenvironmentandorganspecificvariationininvitrocytoprotectiveactivitiesofpiceamarianainpc12cellsexposedtoglucosetoxicityaplantusedfortreatmentofdiabetessymptomsbythecreeofeeyouistcheequebeccanada
AT eidhodam growthenvironmentandorganspecificvariationininvitrocytoprotectiveactivitiesofpiceamarianainpc12cellsexposedtoglucosetoxicityaplantusedfortreatmentofdiabetessymptomsbythecreeofeeyouistcheequebeccanada
AT tangandrew growthenvironmentandorganspecificvariationininvitrocytoprotectiveactivitiesofpiceamarianainpc12cellsexposedtoglucosetoxicityaplantusedfortreatmentofdiabetessymptomsbythecreeofeeyouistcheequebeccanada
AT ahmedfida growthenvironmentandorganspecificvariationininvitrocytoprotectiveactivitiesofpiceamarianainpc12cellsexposedtoglucosetoxicityaplantusedfortreatmentofdiabetessymptomsbythecreeofeeyouistcheequebeccanada
AT harriscorys growthenvironmentandorganspecificvariationininvitrocytoprotectiveactivitiesofpiceamarianainpc12cellsexposedtoglucosetoxicityaplantusedfortreatmentofdiabetessymptomsbythecreeofeeyouistcheequebeccanada
AT haddadpierres growthenvironmentandorganspecificvariationininvitrocytoprotectiveactivitiesofpiceamarianainpc12cellsexposedtoglucosetoxicityaplantusedfortreatmentofdiabetessymptomsbythecreeofeeyouistcheequebeccanada
AT johnstimothy growthenvironmentandorganspecificvariationininvitrocytoprotectiveactivitiesofpiceamarianainpc12cellsexposedtoglucosetoxicityaplantusedfortreatmentofdiabetessymptomsbythecreeofeeyouistcheequebeccanada
AT arnasonjohnt growthenvironmentandorganspecificvariationininvitrocytoprotectiveactivitiesofpiceamarianainpc12cellsexposedtoglucosetoxicityaplantusedfortreatmentofdiabetessymptomsbythecreeofeeyouistcheequebeccanada
AT bennettsteffanyal growthenvironmentandorganspecificvariationininvitrocytoprotectiveactivitiesofpiceamarianainpc12cellsexposedtoglucosetoxicityaplantusedfortreatmentofdiabetessymptomsbythecreeofeeyouistcheequebeccanada
AT cuerrieralain growthenvironmentandorganspecificvariationininvitrocytoprotectiveactivitiesofpiceamarianainpc12cellsexposedtoglucosetoxicityaplantusedfortreatmentofdiabetessymptomsbythecreeofeeyouistcheequebeccanada